This article examines the ethical implications of algorithmic processing in radiology through the distinction between processing and witnessing, two dimensions of medical practice long fused within the single figure of the physician. It argues that as algorithmic systems increasingly absorb the processing component of radiological work (pattern recognition, quantification, classification), witnessing does not disappear but relocates into three mediated channels: the language of the written report, the dialogue between radiologist and referring clinician, and the act of institutional endorsement that follows algorithmic output. Drawing on Levinasian ethics of address and the concept of homo narratus, the article foregrounds what algorithmic processing cannot inherit: the condition of being claimed by another person’s vulnerability, and of answering that claim through language, dialogue, and signature rather than through output alone. Radiology, treated here as a limit case in which processing has advanced furthest, renders this distinction unusually visible before it becomes visible elsewhere in clinical practice. The article addresses a range of objections, including the claim that narrative competence is itself reducible to computational processing, and considers the implications of this argument for the future of medical education, without proposing a specific curricular model. It concludes that as processing becomes increasingly automated across medical specialties, the distinctly human contribution of medicine is likely to rest ever more heavily on witnessing.
Medical tattooing, the application of permanent marks for clinical, rehabilitative, or identification purposes, occupies an unstable position across medical law, consumer regulation, and professional practice. This article argues that the central governance problem is not that law has never encountered irreversible interventions, but that medical tattooing combines enduring bodily alteration with continuing social visibility, informational significance, and fragmented professional responsibility. Permanence should therefore operate as a threshold for enhanced legal and bioethical scrutiny rather than as a sufficient justification for intervention. The article develops a necessity framework under which permanent marking is justified only after reasonable less-permanent alternatives, comparative clinical effectiveness, proportionality, access, and patient-specific values have been considered. It applies this framework to informed consent, institutional responsibility, pediatric care, reconstructive practice, and emerging biosensing tattoos. The analysis also draws on Islamic jurisprudential reasoning on darura while emphasizing that necessity is limited by proportionality and does not override competent refusal. Comparative reference to German and Chinese consent law shows that disclosure of treatment alternatives is already embedded in different legal traditions, but medical tattooing remains poorly integrated into those frameworks. The article concludes that permanent clinical marking requires continuing duties of disclosure, justification, and institutional accountability proportionate to the duration of its consequences.
Gestational diabetes mellitus (GDM) sits at the intersection of maternal bodily integrity, fetal risk mitigation, and healthcare equity, and rigid guideline enforcement can trigger bedside conflicts and institutional friction. This article examines GDM management through the deliberative model of the Spanish physician and philosopher Diego Gracia, influential in Southern Europe and Latin America but less familiar in North America, which separates moral duties into Level I (Non-Maleficence and Justice) and Level II (Autonomy and Beneficence). We explain why we start from Gracia rather than from Beauchamp and Childress: his model couples a defeasible ordering of duties with an explicit deliberative procedure that institutions can teach and document. We then argue against a misreading of the model in perinatal care that places fetal protection at Level I and maternal decision-making at Level II. Maternal bodily integrity and informed refusal also engage Level I non-maleficence duties, so bedside conflicts are better understood as clashes between two Level I obligations. We extend this reframing by translating Gracia’s deliberative steps into a consultation protocol for Healthcare Ethics Committees (HECs), by using international variation in metformin’s regulatory standing to show that pharmacological choice involves value judgments, and by treating access to glucose self-monitoring supplies as a matter of distributive justice. A hypothetical, composite vignette illustrates the protocol. The proposals are conceptual and untested; we suggest that structured deliberation may help institutions honor maternal self-determination without abandoning fetal interests.
Medicine assigns clear professional responsibility for determining and certifying death, but responsibility for determining when irreversible dying has begun is often less clearly assigned. This paper proposes the irreversible dying transition (IDT) as the point at which no medically reasonable intervention can restore a sustainable life-preserving clinical state. IDT is distinct from prognosis, terminal illness, actively dying, the futility of a particular intervention, and decisions to limit treatment. Its purpose is not to introduce another diagnostic label, but to make explicit a specific medical judgment about reversibility that may otherwise remain implicit. The framework distinguishes a life-preservable clinical state, IDT, the irreversible dying process, and death. It argues that when irreversible dying is reasonably in question, a clearly designated physician should assess whether IDT is established, not established, or indeterminate, while drawing on multidisciplinary information and remaining open to reassessment. Shared decision-making cannot substitute for this assessment because patients and families may choose among medically available options but should not be required to determine which options remain restorative. Long-term care settings in Japan provide one practical illustration of this distinction. When physicians are unavailable or involved mainly at the point of death, nurses, care workers, and families may make consequential decisions about transfer, treatment, and continued facility care without a prior medical determination of reversibility. IDT makes clear where responsibility for this judgment lies. Safeguards are required against premature diagnosis, self-fulfilling prophecy, age and disability bias, nominal compliance, and conflation with treatment withdrawal. The concept therefore clarifies a limited but important responsibility: medicine should explicitly address whether irreversible dying has begun, rather than leaving this responsibility to become apparent only after death.
Complete ectogenesis (CE), if technologically realized, would portend a radical decoupling of fetal development from the female body, thereby dismantling the biological and cultural nexus between gestation and kinship. This paper argues that a Confucian approach offers a fruitful framework for critically assessing CE, as it appropriately shifts attention from the moral status or isolated interests of individual entities (such as the fetus, women, or parents) to the quality of relationships—especially the parent-child relationship. From this perspective, CE represents not merely a technical innovation with certain drawbacks, but a morally significant disruption of the relational virtues upon which a good human life depends. When chosen by couples capable of natural reproduction, CE involves the voluntary relinquishment of one of the embodied conditions through which profound parent-child love is ordinarily cultivated, thereby jeopardizing the foundations of human flourishing. The paper concludes by addressing a couple of potential objections to this Confucian critique.
